Design and delivery of nucleic acid drugs for optimization of DNA vaccination
用于优化 DNA 疫苗接种的核酸药物的设计和递送
基本信息
- 批准号:17390041
- 负责人:
- 金额:$ 9.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DNA vaccination, which can induce humoral immunity as well as cellular immunity, is a promising approach for treatment of various infectious diseases and tumors. However, its optimization in terms of design and delivery is required to improve the efficacy of this strategy. In the present study, we examined cellular activation of dendritic cells, the most important cells affecting the efficacy of DNA vaccination, by plasmid DNA in naked and liposomal complex form. We found that dendritic cell activation takes place depending on CpG motifs contained in DNA in both naked and complex forms, which was quite contrast to the observation in macrophages in our previous studies. We also designed novel plasmid constructs encoding antigenic peptide-heat shock protein 70 fusion proteins for controlled intracellular trafficking and subsequent improved activity in cytotoxic T cell activation. We found that intradermal injection of the constructs in combination with electroporation could effectively induce antigen specific cytotoxic T cells and antitumor effect in mice. These findings would provide the useful basis for optimization of delivery and design of plasmid DNA for DNA vaccination.
DNA疫苗接种可以诱导体液免疫和细胞免疫,是治疗各种感染性疾病和肿瘤的一种很有前途的方法。然而,为了提高该策略的有效性,需要在设计和交付方面进行优化。在本研究中,我们通过裸质粒DNA和脂质体复合物形式检测了影响DNA疫苗接种效果的最重要细胞树突状细胞的细胞活化。我们发现树突状细胞的激活依赖于DNA中包含的CpG基序,无论是裸形式还是复杂形式,这与我们之前在巨噬细胞中的观察结果形成鲜明对比。我们还设计了一种新的质粒结构,编码抗原肽-热休克蛋白70融合蛋白,用于控制细胞内运输和随后提高细胞毒性T细胞活化的活性。我们发现皮内注射这些构建物联合电穿孔可以有效地诱导抗原特异性细胞毒性T细胞,并具有抗肿瘤作用。这些发现将为DNA疫苗的传递和质粒设计的优化提供有益的依据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
DNA 及其阳离子脂质复合物诱导小鼠树突状细胞的 CpG 基序依赖性激活。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Akutsu-Yamauchi H;Hitomi J;Satoh Y;Takaharu Yoshinaga et al.
- 通讯作者:Takaharu Yoshinaga et al.
Histogram analysis of pharmacokinetic parameters by bootstrap resampling from one-point data in animal experiments.
通过动物实验中单点数据的引导重采样对药代动力学参数进行直方图分析。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Park;H.-R.;Chijiwa;S.;Furihata;K.;Hayakawa;Y.;Shin-ya;K.;Takemoto S et al.
- 通讯作者:Takemoto S et al.
Cellular uptake and activation characteristics of naked plasmid DNA and its cationic liposome complex in human macrophages.
- DOI:10.1016/j.ijpharm.2005.08.020
- 发表时间:2005-11
- 期刊:
- 影响因子:5.8
- 作者:Ikuko Yamane;M. Nishikawa;Y. Takakura
- 通讯作者:Ikuko Yamane;M. Nishikawa;Y. Takakura
The uptake and degradation of DNA is impaired in macrophages and dendritic cells from NZB/W F(1)mice.
NZB/W F(1) 小鼠的巨噬细胞和树突状细胞中 DNA 的摄取和降解受到损害。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Nakamura Y;Oosaka M;Saino T;Satoh Y:;Ogawa Y et al.
- 通讯作者:Ogawa Y et al.
Plasmid DNA uptake and subsequent cellular activation characteristics in human monocyte-derived cells in primary culture
- DOI:10.1002/jps.20816
- 发表时间:2007-06-01
- 期刊:
- 影响因子:3.8
- 作者:Fukuhara, Yuga;Naoi, Tomoyuki;Takakura, Yoshinobu
- 通讯作者:Takakura, Yoshinobu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKAKURA Yoshinobu其他文献
TAKAKURA Yoshinobu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKAKURA Yoshinobu', 18)}}的其他基金
Optimization of cytokine gene therapy based on the regulation of transcription/translation, pharmacokinetics, and cellular response.
基于转录/翻译、药代动力学和细胞反应调节的细胞因子基因治疗的优化。
- 批准号:
24390008 - 财政年份:2012
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Design and delivery of plasmid vector for spatiotemporal control of the expression of therapeutic protein and siRNA
用于时空控制治疗蛋白和 siRNA 表达的质粒载体的设计和递送
- 批准号:
21390009 - 财政年份:2009
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of all inclusive anti tumor immunotherapy based on engineered protein and nucleic acid
基于工程蛋白和核酸的全包式抗肿瘤免疫疗法的开发
- 批准号:
19390041 - 财政年份:2007
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of novel delivery strategies to dendritic cells and optimization of DNA vaccination
树突状细胞新型递送策略的建立和 DNA 疫苗接种的优化
- 批准号:
15390048 - 财政年份:2003
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of plasmid DNA delivery methods to antigen presenting cells for optimized DNA vaccination
开发质粒 DNA 递送至抗原呈递细胞的方法,以优化 DNA 疫苗接种
- 批准号:
13470514 - 财政年份:2001
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of local drug disposition analysis and delivery methods in human solid tumors
人类实体瘤局部药物分布分析和递送方法的开发
- 批准号:
12557212 - 财政年份:2000
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
遺伝子医薬品の体内動態および細胞取り込み機構の解明に基づくデリバリー戦略の確立
阐明基因药物的药代动力学和细胞摄取机制,建立递送策略
- 批准号:
11672257 - 财政年份:1999
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Gene Delivery Systems to Intestinal Epithelial Cells as a Target
以肠上皮细胞为靶标的基因传递系统的开发
- 批准号:
09672324 - 财政年份:1997
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Delivery Systems for the Control of Pharmacokinetics and Intracellular Trafficking of Antisense Drugs
开发用于控制反义药物的药代动力学和细胞内运输的递送系统
- 批准号:
07672351 - 财政年份:1995
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Elucidating type 1 conventional dendritic cell-dependent anti-tumour immune responses in brain metastases
阐明脑转移瘤中 1 型传统树突状细胞依赖性抗肿瘤免疫反应
- 批准号:
MR/Y013328/1 - 财政年份:2024
- 资助金额:
$ 9.6万 - 项目类别:
Research Grant
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
浆细胞样树突状细胞发育和功能的分子控制
- 批准号:
10583989 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Intestinal Microbiota Affect Stroke Outcome by Modulating the Dendritic Cell-regulatory T Cell Axis
肠道微生物群通过调节树突状细胞调节 T 细胞轴影响中风结果
- 批准号:
10751249 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
The Effect Of Malaria Parasites On Dendritic Cell Metabolism (TEMPODM)
疟原虫对树突状细胞代谢的影响 (TEMPODM)
- 批准号:
BB/X00029X/1 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Research Grant
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
转移部位对树突状细胞驱动的肿瘤免疫的影响
- 批准号:
10738428 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Probing the effect of dendritic cell co-stimulatory ligand lateral mobility on T cell mediated immunity and tolerance
探讨树突状细胞共刺激配体横向移动对T细胞介导的免疫和耐受的影响
- 批准号:
BB/X015408/1 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Research Grant
Dendritic cell targeting by bacterial LysM proteins to suppress inflammation
树突状细胞通过细菌 LysM 蛋白靶向抑制炎症
- 批准号:
10750594 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Induced pluripotent stem cell-derived dendritic cell vaccine therapy genetically modified to express neo-antigen
诱导多能干细胞衍生的树突状细胞疫苗疗法经过基因改造以表达新抗原
- 批准号:
23K08160 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted Gene Delivery and Human Dendritic Cell Maturation Through a Novel Hybrid Biological-Biomaterial Vector System
通过新型混合生物-生物材料载体系统进行靶向基因递送和人类树突状细胞成熟
- 批准号:
10586414 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Development of combination immunotherapy using MHC inducer and dendritic cell vaccine against pancreatic cancer
使用MHC诱导剂和树突状细胞疫苗对抗胰腺癌的联合免疫疗法的开发
- 批准号:
23K19511 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Research Activity Start-up














{{item.name}}会员




